UM’s Rodolfo Galindo is part of a team studying the impact of continuous glucose monitoring devices, which record thousands of measurements each day for patients with diabetes, instead of traditional single-point HbA1c blood glucose tests. CGM devices record thousands of measurements each day, showing real-time changes and helping doctors and patients spot dangerous highs and lows that the traditional blood test can’t detect.

The team examined data from randomized controlled trials, observational cohorts, and cross-sectional studies. People with type 2 diabetes that used CGMs experienced significant improvements in their glucose levels, spent more time in the healthy range, and faced fewer episodes of low blood sugar. “CGM devices have revolutionized diabetes care … The new frontier will be continuous monitoring of other human electrolytes like sodium, calcium, potassium or disease biomarkers like ketones.”  

• Rodolfo Galindo